n ovarian carcinoma cell proliferation:a potential role for inducible nitric oxide synthase[J]. Gynecol Oncol,2001,82:127131
6Viqar SY,Gregory U,Samuel C, et al.Expression of receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelilal cells[J].Cancer Res,2001,61:67686776
7Formelli F,Cleris L.Synthetic retinoid fenretinide is effective against a human ovaeian carcinoma xenograft and potentates cisplatin activity[J].Cancer Res, 1993,53:53745378
8曹泽毅.中华妇产科学[M].北京：人民卫生出版社, 2000. 15101512
9Marth C,Daxenbichler G,Dapunt O.Synergistic antiprolif
erative effect of human recombinant interferons and retinoic acid in culturede breast cancer cells[J].J Natl Cancer Inst, 1986,77:11971202
10Chen ZX, Xue YQ, Zang RF, et al.A clinical and experimental study on alltrans retinoic acidtreated acute promyelocytic leukemia patient[J].Blood, 1991,78:14131421
11Formrlli F, Carsana R, Costa A,et al.Plasma retinal level reduction by the synthetic retinoid:a one year followup study of breast cancer patients[J].Cancer Res, 1989,49:61496157
12Moon RC,Mehta RG, Detrisac CL.Retinoids as chemopreventive agents for breast cancer cells[J].Cancer Detect Prev, 1992,16:7381
13Kommoss F, Pfisterer J, Thome M, et al.Steroid receptor in ovarian carcinoma:immuneohistochemical determination may lead to new aspects[J].Gynecol Oncol,1992,47:317322
14Hempling RE, Piver MS, Eltabbakj GH, et al.Progesterone receptor status is a significant prongostic variable of progressionfree survival in advanced epithelial ovarian cancer[J].Am J Clin Oncol,1998,21(5):447451
15Langdon SP,Gabra H,Bartlerr JM, et al.Funcrionality of the progesterone receptor in ovarian cancer and its regulation by estrogen[J].Clin Cancer Res,1998,4(9): 22452251
16Sevelda P,Denison U,Schemper M,et al.Oestrogen and progesterone receptor content as a prongostic factor in advanced epith
上一页 [1] [2] [3] [4] [5] [6] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 妇产科论文 >> 正文